Molecular engineering of L-asparaginases used in antileukemic therapy.

Konrad, M.

Local TagsRelease HistoryDetailsSummary

Molecular engineering of L-asparaginases used in antileukemic therapy.

Konrad, M. (2015). Molecular engineering of L-asparaginases used in antileukemic therapy. FEBS Journal, 282(Suppl. 1), 159-159.

Item is Released

show all hide all

Basic

show hide

Item Permalink: https://hdl.handle.net/11858/00-001M-0000-0029-0AC1-C Version Permalink: https://hdl.handle.net/11858/00-001M-0000-002A-165E-D

Genre: Conference Paper

Files

show Files

Locators

show

hide

Locator:
http://onlinelibrary.wiley.com/doi/10.1111/febs.2015.282.issue-S1/issuetoc (Publisher version) Open Access status unknown

Description:
-

OA-Status:

Creators

show

hide

Creators:
Konrad, M.¹, Author

Affiliations:
1Research Group of Enzyme Biochemistry, MPI for biophysical chemistry, Max Planck Society, ou_578612

Content

show

Details

show

hide

Language(s): eng - English

Dates: Published Online: 2015-07

Publication Status: Published online

Pages: -

Publishing info: -

Table of Contents: -

Rev. Type: -

Identifiers: -

Degree: -

Event

show

hide

Title: 40th Congress of the Federation of European Biochemical Societies (FEBS) - The Biochemical Basis of Life

Place of Event: Berlin

Start-/End Date: 2015-07-04 - 2015-07-09

Legal Case

show

Project information

show

Source 1

show

hide

Title: FEBS Journal

Source Genre: Journal

Creator(s):

Affiliations:

Publ. Info: -

Pages: - Volume / Issue: 282 (Suppl. 1) Sequence Number: - Start / End Page: 159 - 159 Identifier: -